Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
abbvie
adalimumab (humira)
aducanumab
aduro biotech
affordable care act
alez azar
alzheimer's disease
antibiotics
axial spondyloarthritis
bausch health
biogen
biotech
blackberry
boston blog main
boston top stories
boston university
boulder/denver blog main
boulder/denver top stories
bristol-myers squibb
business
cancer
cancer immunotherapy
car-t immunotherapy
cell therapy
clinical trials
cluster headache
crispr
deals
detroit blog main
detroit top stories
diagnostics
digital health
dihydroergotamine
dimitry nuyten
drug prices
eddingpharm
eli lilly
elizabeth holmes
fremanezumab
fulcrum therapeutics
What
remains
2
×
strategy
2
×
acknowledged
approval
bio
biogen’s
biopharmaceutical
blackberry
ceo
companies
company
convo
devices
drug
earlier
effort
failures
hollywood
lays
littered
medical
movie
nash
new
news
price
products
progress
road
roundup
safeguard
scripts
security
shape
showcased
suite
takes
talk
thursday
transform
Language
Current search:
remains
×
strategy
×
@xconomy.com
5 years ago
Bio Roundup: Biogen’s Strategy, Drug Price Convo, NASH News & More
@venturebeat.com
8 years ago
BlackBerry lays out security strategy as turnaround takes shape
